Retreatment of hepatitis C non-responsive to Interferon: a placebo controlled randomised trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux

Completed

• Conditions: Chronic hepatitis C; Infections and Infestations; Hepatitis

• Registration Number: ISRCTN53821378
• Lead Sponsor: Schering Plough International (USA)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2003-08-11
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 117

Inclusion Criteria

Patients with chronic hepatitis C and elevated transaminases who did not respond to previous treatment with standard interferon monotherapy.

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ot provided at time of registration

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration